Foreword Peter A. McCulloughPrefacePart One Epidemiology Chapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical Problems Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD Risk Chapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle PrefacePart One Epidemiology Chapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure Ruth C. Campbell and Ali Ahmed Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients: What is the best way to achieve and what is the desired hemoglobin? Tejas V. Patel and Ajay K. Singh Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical Problems Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD Risk Chapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Ivana Lazich and George L. Bakris Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical Problems Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD Risk Chapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle Mohammed Shakaib and George L. Bakris Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient Biff F. Palmer Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications Ivan D. Hanson and Peter A. McCullough Part Three Management of Kidney Associated Clinical Problems Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure Julian Segura and Luis M. Ruilope Chapter 8 Management of Heart Failure with Renal Artery Ischaemia Andrew K. Roy and Patrick Murray Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica Chapter 11 Ultrafiltration and Heart Failure Paul Chacko, Donald Kikta Jr., William T. Abraham Part Four Advances in Nephropathy Management: Influences on CVD Risk Chapter 12 Combination Therapy in Hypertension Treatment Raymond V. Oliva and George L. Bakris Chapter 13 Medication Adherence in Heart Failure Daniel E. Hilleman and Jennifer A. Campbell Chapter 14 New Markers of Vascular Risk David Davidson and Michael H. Davidson Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD Raghu V. Durvasula and Katherine R. Tuttle